The UK Health Security Agency (UKHSA) has launched an urgent appeal for families to check eligibility for a free meningococcal B (MenB) vaccine, targeting teenagers born between September 1, 2007 and August 31, 2008, who have completed Year 13 in summer 2026, as well as first-year university students under 25.
In a social media post shared with its 190,000 followers, the UKHSA advised parents to "tag" anyone in Year 13 or heading to university this autumn, warning that thousands of eligible teenagers risk missing the jab. The agency stated that just two doses "helps protect against serious illnesses like meningitis."
Eligibility Criteria
According to official NHS guidance, the free vaccine is available to everyone who completes Year 13 in summer 2026, born between September 1, 2007 and August 31, 2008, regardless of whether they pursue further study. Also eligible are people under 25 starting university or moving into certain residential further education accommodation for the first time this autumn, including international students arriving in September.
Officials stressed that the offer does not extend to everyone on campus. Postgraduates and students beyond their first year are not covered.
Urgency After Outbreaks
The one-off programme has been fast-tracked after a string of outbreaks in 2026, most notably at the University of Kent in March, where two students died. Meningitis charities reported that the outbreak claimed the life of 18-year-old Juliette Kenny, whose family has since campaigned for wider access to the jab. Further clusters were recorded in Weymouth and Reading.
Health Secretary James Murray said the Kent tragedy and subsequent clusters pointed to a "possible change to the way MenB affects people," adding that ministers were "acting now to help protect young people at highest immediate risk" while a fuller review is carried out.
Dr. Shamez Ladhani, a consultant epidemiologist at UKHSA, said outbreaks of the disease were rare but could be devastating, and that two doses were "essential" to give families reassurance as their children head off to halls.
Risk and Statistics
Meningitis charities warn that meningococcal infection can trigger meningitis and blood poisoning, is fatal in around 10% of cases, and can leave survivors with life-changing injuries including amputations, hearing loss, and brain damage. First-year university students face a risk roughly seven times greater than their peers not in higher education, due to close mixing in halls, at parties, and on nights out.
UKHSA figures show there were 313 confirmed cases of MenB in England in 2024 to 2025 alone, accounting for 83% of all invasive meningococcal disease recorded. Doctors say the bacteria can spread through everyday contact including kissing, sharing drinks or vapes, or living in close quarters.
Vaccination Process
Vaccination will be delivered through the NHS from late July, with the first dose offered from July 20 and the second in August, at least 28 days apart. Year 13 pupils will be contacted directly via text, email, letter, or the NHS App and invited to book at a local pharmacy. University and college freshers can walk into a participating pharmacy once term begins.
Families are urged not to delay, as cases typically surge in October and November when students settle into halls. Common side effects are mild and may include sore arm, mild fever, headache, or nausea. Anyone unsure of eligibility should check the NHS website or contact their GP.
